Distillate Capital Partners LLC Bristol Myers Squibb CO Transaction History
Distillate Capital Partners LLC
- $595 Million
- Q1 2024
A detailed history of Distillate Capital Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Distillate Capital Partners LLC holds 248 shares of BMY stock, worth $10,299. This represents 2.26% of its overall portfolio holdings.
Number of Shares
248
Previous 209
18.66%
Holding current value
$10,299
Previous $10.7 Million
25.41%
% of portfolio
2.26%
Previous 2.33%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.73 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.75 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.8 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.69 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.92 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $88.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...